$709 Million is the total value of SABBY MANAGEMENT, LLC's 162 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CJJD | Exit | CHINA JO JO DRUGSTORES INC | $0 | – | -25,000 | -100.0% | -0.01% | – |
| Exit | AETERNA ZENTARIS INCcall | $0 | – | -462 | -100.0% | -0.01% | – | |
| PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -15,000 | -100.0% | -0.01% | – |
| Exit | DIGITAL ALLY INCcall | $0 | – | -309 | -100.0% | -0.01% | – | |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -10,815 | -100.0% | -0.02% | – |
| Exit | ACTINIUM PHARMACEUTICALS INCput | $0 | – | -100 | -100.0% | -0.02% | – | |
| Exit | POLARITYTE INCput | $0 | – | -1,355 | -100.0% | -0.03% | – | |
| RVPHW | Exit | REVIVA PHARMACEURICALS HLDGS INC*w | $0 | – | -350,000 | -100.0% | -0.03% | – |
| NTEC | Exit | INTEC PHARMA LTD | $0 | – | -37,501 | -100.0% | -0.03% | – |
| RKDA | Exit | ARCADIA BIOSCIENCES INC | $0 | – | -67,136 | -100.0% | -0.04% | – |
| CLGN | Exit | COLLPLANT BIOTECHNOLOGIES LTDads | $0 | – | -17,045 | -100.0% | -0.04% | – |
| PTE | Exit | POLARITYTE INC | $0 | – | -210,562 | -100.0% | -0.05% | – |
| PSTI | Exit | PLURISTEM THERAPEUTICS INC | $0 | – | -50,822 | -100.0% | -0.05% | – |
| Exit | CARDIFF ONCOLOGY INCcall | $0 | – | -275 | -100.0% | -0.05% | – | |
| AGFY | Exit | AGRIFY CORP | $0 | – | -21,342 | -100.0% | -0.05% | – |
| Exit | ADAMIS PHARMACEUTICALS CORPput | $0 | – | -3,034 | -100.0% | -0.06% | – | |
| Exit | AVEO PHARMACEUTICALS INCput | $0 | – | -620 | -100.0% | -0.09% | – | |
| MITO | Exit | STEALTH BIOTHERAPEUTICS CORPads | $0 | – | -301,575 | -100.0% | -0.09% | – |
| BPTH | Exit | BIO PATH HLDGS INC | $0 | – | -71,920 | -100.0% | -0.10% | – |
| IWM | Exit | ISHARES RUSSELL 2000etf | $0 | – | -2,372 | -100.0% | -0.10% | – |
| BFLY | Exit | BUTTERFLY NETWORK INC | $0 | – | -33,047 | -100.0% | -0.11% | – |
| CTXR | Exit | CITIUS PHARMACEUTICALS INC | $0 | – | -314,000 | -100.0% | -0.11% | – |
| HEPA | Exit | HEPION PHARMACEUTICALS INC | $0 | – | -306,338 | -100.0% | -0.11% | – |
| NMTR | Exit | 9 METERS BIOPHARMA INC | $0 | – | -564,527 | -100.0% | -0.13% | – |
| HMCOU | Exit | HUMANCO ACQUISITION CORPunit | $0 | – | -67,974 | -100.0% | -0.14% | – |
| Exit | CURIS INCcall | $0 | – | -985 | -100.0% | -0.18% | – | |
| CLBS | Exit | CALADRIUS BIOSCIENCES INC | $0 | – | -484,970 | -100.0% | -0.18% | – |
| Exit | SPI ENERGY CO LTD | $0 | – | -131,898 | -100.0% | -0.19% | – | |
| AUPH | Exit | AURINIA PHARMACEUTICALS | $0 | – | -85,625 | -100.0% | -0.22% | – |
| XBI | Exit | SPDR SERIES TRUSTetf | $0 | – | -8,735 | -100.0% | -0.23% | – |
| Exit | SAGE THERAPEUTICS INCput | $0 | – | -166 | -100.0% | -0.24% | – | |
| Exit | ARKput | $0 | – | -114 | -100.0% | -0.27% | – | |
| XELA | Exit | EXELA TECHNOLOGIES | $0 | – | -750,000 | -100.0% | -0.32% | – |
| Exit | IONIS PHARMACEUTICALScall | $0 | – | -428 | -100.0% | -0.37% | – | |
| Exit | ASENSUS SURGICAL INCcall | $0 | – | -6,556 | -100.0% | -0.42% | – | |
| RVPH | Exit | REVIVA PHARMACEURICALS HLDGS INC | $0 | – | -418,437 | -100.0% | -0.47% | – |
| Exit | CEL-SCI CORPcall | $0 | – | -1,760 | -100.0% | -0.52% | – | |
| Exit | BIOGEN INCput | $0 | – | -100 | -100.0% | -0.54% | – | |
| VTSI | Exit | VIRTRA INC | $0 | – | -561,088 | -100.0% | -0.67% | – |
| PENN | Exit | PENN NATIONAL GAMING INC | $0 | – | -40,399 | -100.0% | -0.82% | – |
| VXX | Exit | BARCLAYS BANK PLCetf | $0 | – | -525,000 | -100.0% | -1.16% | – |
| Exit | PENN NATIONAL GAMING INCput | $0 | – | -731 | -100.0% | -1.49% | – | |
| Exit | SPDR GOLD TRUSTcall | $0 | – | -966 | -100.0% | -3.01% | – | |
| Exit | BARCLAYS BANK PLCcall | $0 | – | -14,336 | -100.0% | -3.18% | – | |
| Exit | BIOGEN INCcall | $0 | – | -1,518 | -100.0% | -8.26% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.